Chronic Obstructive Pulmonary Disease (COPD)NCT07171957
Motor Imagery in Chronic Obstructive Pulmonary Disease
An observational study of Chronic Obstructive Pulmonary Disease (COPD) and Mental Imagery, run by Kutahya Health Sciences University at 1 site in Turkey (Türkiye).
Trial summary
The purpose of this study was to compare the motor imagery ability of individuals with Chronic Obstructive Pulmonary Disease (COPD) with those without COPD. Read more about this study
- Who is it for?
- Ages 40 to 70 yearsHealthy volunteers can take part
- Conditions the study is for
- Chronic Obstructive Pulmonary Disease (COPD), Mental Imagery
- How many people
- 188 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Aug 2025to 30 Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 70 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Chest diseases clinic
Who may be able to join
- Being between 40-70 years of age
- Being diagnosed with COPD
- Having 24 points or more on the Mini Mental State Examination
- Not having a history of acute exacerbation and/or hospitalization in the last month and being clinically stable
Who cannot join
- Being between 40-70 years old
- Having a score of 24 or above on the Mini Mental State Examination
- Not having any pulmonary, cardiac, orthopedic or neurological disease
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Investigation of Motor Imagery in Individuals With Chronic Obstructive Pulmonary Disease
The purpose of this study was to compare the motor imagery ability of individuals with Chronic Obstructive Pulmonary Disease (COPD) with those without COPD.
Read the detailed description
The study will begin after receiving approval from the KSBU Non-Interventional Ethics Committee for its compliance. Before data collection begins, each participant who agrees to the study will be informed about the study, and will be asked to sign a voluntary consent form. After obtaining demographic and disease-specific information, participants will be divided into two groups: COPD and non-COPD individuals, and their cognitive skills, dominant hand preference, and motor imagery abilities will be assessed. The cognitive functions of all participants will be assessed using the Standardized Mini Mental State Examination. Participants will be included in the study if they score ≥24. The dominant hand preference of the participants will be determined using the Edinburgh Hand Preference Questionnaire and recorded on the assessment form. In the tests and surveys to be conducted, the dominant hand will be determined based on the results of this questionnaire, and the results of tests performed with the dominant side will be recorded. The GOLD ABE Assessment Tool will be used to assess COPD patients. As part of the GOLD ABE Assessment Tool, patients' pulmonary function test results, COPD Assessment Test (CAT) results, Modified Health Research Council Dyspnoea Scale (mMRC) results, exacerbation history, and hospitalization history will be recorded. Oxygen saturation values of COPD patients will be recorded. Routine measurement results for oxygen saturation and pulmonary function test values of individuals with COPD will be recorded. Participants' motor imagery skills will be assessed using the Kinesthetic and Visual Motor Imagery Questionnaire-20 (KVIQ-20). The Nine-Hole Peg Test will be used to assess the temporal correspondence between participants' actual and imagined movement (mental chronometry). Temporal correspondence between actual and imagined movement will be calculated using the formula. Participants' mental rotation abilities will be assessed using the hand laterality test (hand identification test), one of the mental rotation subcomponents, using the Recognise Hand mobile application. Data obtained from individuals with COPD and individuals without COPD will be recorded. Based on the data obtained, the motor imagery abilities of the two groups will be compared using appropriate statistical methods. The correlation between the disease-specific knowledge of individuals in the COPD group and their motor imagery abilities will be calculated.
- Keywords
- mental imagery, Chronic Obstructive Pulmonary Disease
- Medical subject headings
- Pulmonary Disease, Chronic Obstructive
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| COPD group | Study group | |
| Control Group | Healthy group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Kinesthetic and Visual Motor Imagery Questionnaire-20 (KVIQ-20)
Developed to assess imagery ability, the questionnaire aims to determine the extent to which individuals visualize and feel the movements they imagine. The KVIQ-20 consists of 10 visual and 10 kinesthetic items that assess head, shoulders, trunk, upper extremity, and lower extremity movements. All 10 movements are performed in a sitting position. The KVIQ uses a 5-point scale to rate the clarity of imagery (Visual subscale) and the intensity of sensations (Kinesthetic subscale); a score of 5 corresponds to the highest level of imagery and a score of 1 corresponds to the lowest level of imagery. During the test, bilateral assessments are performed. A validity and reliability study for the Turkish version was conducted by Dilek and colleagues. Individuals will be instructed to use a first-person perspective during the MI.
Measured: Baseline (First assessment)
Secondary outcomes (2)
Mental Chronometry Test
The Nine-Hole Peg Test (NHPT) will be used to assess the temporal correspondence between real and imagined movement. The test material consists of nine standard-sized small pegs and a wooden board with nine holes to insert them. The NHPT will be administered with the patient in a sitting position. The patient will be asked to place nine pegs in a box on a table as quickly as possible into the holes of another box, and once completed, immediately remove them and place them back in the same box. The test will be performed with the dominant hand. The test time will be measured with a stopwatch, starting when the hand touches the pegs and ending when the last peg is placed in the box. Subjects will then be asked to imagine performing the NHPT without performing any movement. The time will be started with the command "start," and the subject will mentally imagine the NHPT without actually performing any movement. Upon completion of the test, the time will be stopped when the word "stop" is
Measured: Baseline (First assessment)
Mental Rotation Test
Mental rotation is one of the visual-spatial abilities and can be simply defined as the rotation of objects in 3D. The hand laterality test (hand identification test), one of the subcomponents of mental rotation, will be assessed using the Recognise Hand mobile app. The app was developed and released by NOI Group™. The Recognise Hand app has been shown to accurately measure left-hand-right discrimination and reaction time as part of a stepwise motor imagery rehabilitation program. The app will use a "Vanilla" mode, displaying 20 images at 5-second intervals. Patients will be instructed to respond as quickly as possible whether the image is the right or left hand.
Measured: Baseline (First assessment)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Sep 2025
- Study start1 Aug 2025
- Primary completion30 Sep 2026 (estimated)
- Study completion30 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic Obstructive Pulmonary Disease (COPD)Studies of the same condition, open and under way.
- More trials run by Kutahya Health Sciences UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Enrolment
- 188 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Kutahya Health Sciences University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Lütfiye AKKURT, MSc, Kutahya Health Sciences University
- Investigators
- Lütfiye AKKURT, Asst.Prof., Study director, Kütahya Health Sciences Universityİlknur KAYA, Asst.Prof., Study chair, Kütahya Health Sciences University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07171957
- Sponsor's protocol ID
- 2025/07-09
- Status last verified
- Sep 2025
- First submitted
- 3 Sep 2025
- Last updated
- 15 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigation of Motor Imagery in Individuals With Chronic Obstructive Pulmonary Disease
- ClinicalTrials.gov ID
- NCT07171957
- Acronym / sponsor ID
- 2025/07-09
- Keywords
- mental imagery, Chronic Obstructive Pulmonary Disease
- Study type
- Observational
- Recruitment status
- Enrolling by invitation
- Enrolment
- 188 participants (estimated)
- Lead sponsor
- Kutahya Health Sciences UniversityUniversity, hospital or other
- Study start
- 1 Aug 2025 (actual)
- Primary completion
- 30 Sep 2026 (estimated)
- Study completion
- 30 Dec 2026 (estimated)
- First posted
- 15 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study was to compare the motor imagery ability of individuals with Chronic Obstructive Pulmonary Disease (COPD) with those without COPD.
Detailed description
The study will begin after receiving approval from the KSBU Non-Interventional Ethics Committee for its compliance. Before data collection begins, each participant who agrees to the study will be informed about the study, and will be asked to sign a voluntary consent form. After obtaining demographic and disease-specific information, participants will be divided into two groups: COPD and non-COPD individuals, and their cognitive skills, dominant hand preference, and motor imagery abilities will be assessed. The cognitive functions of all participants will be assessed using the Standardized Mini Mental State Examination. Participants will be included in the study if they score ≥24. The dominant hand preference of the participants will be determined using the Edinburgh Hand Preference Questionnaire and recorded on the assessment form. In the tests and surveys to be conducted, the dominant hand will be determined based on the results of this questionnaire, and the results of tests performed with the dominant side will be recorded. The GOLD ABE Assessment Tool will be used to assess COPD patients. As part of the GOLD ABE Assessment Tool, patients' pulmonary function test results, COPD Assessment Test (CAT) results, Modified Health Research Council Dyspnoea Scale (mMRC) results, exacerbation history, and hospitalization history will be recorded. Oxygen saturation values of COPD patients will be recorded. Routine measurement results for oxygen saturation and pulmonary function test values of individuals with COPD will be recorded. Participants' motor imagery skills will be assessed using the Kinesthetic and Visual Motor Imagery Questionnaire-20 (KVIQ-20). The Nine-Hole Peg Test will be used to assess the temporal correspondence between participants' actual and imagined movement (mental chronometry). Temporal correspondence between actual and imagined movement will be calculated using the formula. Participants' mental rotation abilities will be assessed using the hand laterality test (hand identification test), one of the mental rotation subcomponents, using the Recognise Hand mobile application. Data obtained from individuals with COPD and individuals without COPD will be recorded. Based on the data obtained, the motor imagery abilities of the two groups will be compared using appropriate statistical methods. The correlation between the disease-specific knowledge of individuals in the COPD group and their motor imagery abilities will be calculated.
Study design
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| COPD group | – | –Study group |
| Control Group | – | –Healthy group |
Who may qualify
- Ages
- 40 to 70 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Chest diseases clinic
Key inclusion criteria (4 listed)
- Being between 40-70 years of age
- Being diagnosed with COPD
- Having 24 points or more on the Mini Mental State Examination
- Not having a history of acute exacerbation and/or hospitalization in the last month and being clinically stable
Key exclusion criteria (3 listed)
- Being between 40-70 years old
- Having a score of 24 or above on the Mini Mental State Examination
- Not having any pulmonary, cardiac, orthopedic or neurological disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Kinesthetic and Visual Motor Imagery Questionnaire-20 (KVIQ-20)
Time frame: Baseline (First assessment)
Developed to assess imagery ability, the questionnaire aims to determine the extent to which individuals visualize and feel the movements they imagine. The KVIQ-20 consists of 10 visual and 10 kinesthetic items that assess head, shoulders, trunk, upper extremity, and lower extremity movements. All 10 movements are performed in a sitting position. The KVIQ uses a 5-point scale to rate the clarity of imagery (Visual subscale) and the intensity of sensations (Kinesthetic subscale); a score of 5 corresponds to the highest level of imagery and a score of 1 corresponds to the lowest level of imagery. During the test, bilateral assessments are performed. A validity and reliability study for the Turkish version was conducted by Dilek and colleagues. Individuals will be instructed to use a first-person perspective during the MI.
2 secondary outcomes
Mental Chronometry Test
Time frame: Baseline (First assessment)
Mental Rotation Test
Time frame: Baseline (First assessment)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Sep 2025.
- Individual participant dataSharing planned: No
Related trials for Chronic Obstructive Pulmonary Disease (COPD)
Not yet recruitingPhase 1/2
cfMSC Stem Cell Therapy Targeting COPD
Chronic Obstructive Pulmonary Disease (COPD)
Recruiting
Multimodal Assessment of NMES Effects on Respiratory and Peripheral Muscles in COPD
Chronic Obstructive Pulmonary Disease (COPD), Respiratory Muscle Dysfunction
RecruitingPhase 2/3
A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe Disease
RSV
Enrolling by invitationObservational study
Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)
Anosmia, Chronic Obstructive Pulmonary Disease
RecruitingObservational study
Construction and Validation of an Impulse Oscillometry (IOS)-Based Platform for Screening, Diagnosis, and Management of Chronic Airway Diseases
Chronic Obstructive Pulmonary Disease (COPD), Asthma (Diagnosis)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Lütfiye AKKURT, Asst.Prof. study director
Kütahya Health Sciences University
İlknur KAYA, Asst.Prof. study chair
Kütahya Health Sciences University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Chronic Obstructive Pulmonary Disease (COPD) and Mental Imagery, run by Kutahya Health Sciences University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 15 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Kinesthetic and Visual Motor Imagery Questionnaire-20 (KVIQ-20) (time frame: Baseline (First assessment)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2025.